Pharmaceuticals

Age Differences in Benefit-Risk Perception

This research is exploring the role of older age in patients’ perceptions of the benefits and risks of medical treatments.

Selected publications and presentations:

  • Balog-Way, D.H.P. & Löfstedt, R.E. (2020) Pharmaceutical Benefit-Risk Perception and Older Age: A Pilot Study. Therapeutic Innovation and Regulatory Science, Advanced Online Publication
  • Balog-Way, D.H.P. (2019) Talking about My Generation (Part III): Benefit-Risk Communication and Older Adults. 9th Annual Ditchley Group Forum. Convento do Espinheiro, Évora, Portugal, June 21-22.
  • Balog-Way, D.H.P. (2019) Talking about My Generation: Exploring Benefit-Risk Communication and Older Adults. Drug Information Association Europe’s (DIA-E) Annual Meeting, Vienna, Austria, February 5-7
  • Balog-Way, D.H.P. (2018) Medicines for Older People: The Importance of Experience in Benefit-Risk Decision-Making. 8th Annual Ditchley Group Forum. Kerckebosch Castle, Zeist, Netherlands, May 24-25.

Transparency and Trust in Medicines

This research is examining the role of trust and transparency in the pharmaceutical sector.

Selected publications and presentations:

  • Balog-Way, D.H.P., Evensen D.T., Löfstedt, R.E. & Bouder, F.E. (2019) Effects of Public Trust on Behavioural Intentions: Data from Six EU Countries. Journal of Risk Research. Advanced Online Publication.
  • Balog-Way, D.H.P. (2019) Bridging the Risk-Science Policy Gap: Are Regulatory Agencies Ready? Society for Risk Analysis’s (SRA) Annual Meeting. Arlington, VA, December 8-12.
  • Way, D.H.P., Evensen, D.T., Löfstedt, R.E. & Bouder, F.E. (2016) Medicines Transparency and Trust in Europe: Results from Six Member State Surveys. Society for Risk Analysis’s (SRA) Annual Meeting. San Diego, CA, USA, December 11-15.